Top 20 reports

1. Strokefinder MD100 microwave tomography for early diagnosis of stroke type - Mar  2014

2. BreathLink™ for breast cancer screening - Jan  2014

3. Ibrutinib for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line - Jul  2013

4. Sofosbuvir with ledipasvir for hepatitis C, genotype 1 - Aug  2013

5. RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria - May  2014

6. Aflibercept (Eylea) for visual impairment due to diabetic macular oedema – first line - Jun  2013

7. Non-marker based circulating tumour cell capture for solid malignant tumours - Apr  2014

8. New and emerging technologies for inherited retinal diseases - Jul  2014

9. Sheffield Support Snood for neurodegenerative conditions - Feb  2014

10. Liraglutide for obesity or overweight in patients with associated co-morbidities - Oct  2013

11. Asfotase alfa for hypophosphatasia - Dec  2013

12. Eliglustat for Gaucher disease - Jun  2013

13. Apremilast for psoriasis - Jan  2013

14. New and emerging technologies for urinary and faecal incontinence - Mar  2014

15. Brentuximab vedotin (Adcetris) for Hodgkin lymphoma - Jul  2013

16. Ellex 2RT™ for early age-related macular degeneration - Nov  2013

17. Idelalisib with rituximab for chronic lymphocytic leukaemia - Jul  2013

18. Lumacaftor and ivacaftor combination therapy for cystic fibrosis – first line - Feb  2014

19. Daclatasvir and sofosbuvir (Sovaldi) with and without ribavirin for chronic hepatitis C infection - Apr  2014

20. Curodont™ Repair and Curodont Protect™ for the treatment and prevention of tooth decay - Jul  2013

Pause Ticker Next Item Previous Item

What’s new on the site

View all outputs

Latest news articles


What treatments are coming for inherited retinal diseases?

The NIHR Horizon Scanning Centre has published the latest horizon scanning review, this time about health technologies in development for ...

What’s coming in cervical cancer screening?

In women under the age of 35, cervical cancer is the most common form of cancer. The main cause of cervical cancer is infection with the h...

Latest Medtech Alerts

The following Medtech Alerts on innovative new and emerging medical devices and diagnostics have recently been uploaded to our website: Ae...

Latest pharmacological technology briefings now available

Our latest batch of briefings on pharmacological technologies in development is now available. These include briefings in the following sp...

Latest briefings on pharmacological technologies for the treatment of cancer

Our latest batch of briefings on pharmacological technologies in development for the treatment of cancer is now available. These include: ...

View all articles

Join Our Mailing list

Our regular newsletter contains a quick roundup of the latest news, briefings and reports on Horizon Scanning

Follow us on Twitter

Seven pharma companies offer up deprioritised pharmaceutical compounds to UK researchers @MRCcomms @ABPI_UK

Jul 22, 2014, 3:29 pm